GETI-B:STO
Getinge publ AB
SEK २५०.००
arrow_downward
-०.२४%(-०.६०) 1D
अक्टोबर ७, १७:२९:४९ GMT+२ · SEK
search
All symbols
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for GETI-B...
Open
SEK २५०.४०
High
SEK २५२.३०
Low
SEK २४८.४०
Mkt. cap
६३.०० अरब
Avg. vol.
५.७८ लाख
Volume
७.४९ लाख
Dividend
१.९०%
Quarterly dividend
SEK १.१९
Ex-dividend date
२०२६ अप्रिल २२
P/E ratio
२५.४६
52-wk high
SEK २५२.३०
52-wk low
SEK १७५.९०
EPS
SEK ९.८२
Shares outstanding
२५.४२ करोड
No. of employees
१२ हजार
Open
SEK २५०.४०
High
SEK २५२.३०
Low
SEK २४८.४०
Mkt. cap
६३.०० अरब
Avg. vol.
५.७८ लाख
Volume
७.४९ लाख
Dividend
१.९०%
Quarterly dividend
SEK १.१९
Ex-dividend date
२०२६ अप्रिल २२
P/E ratio
२५.४६
52-wk high
SEK २५२.३०
52-wk low
SEK १७५.९०
EPS
SEK ९.८२
Shares outstanding
२५.४२ करोड
No. of employees
१२ हजार
News stories
From web sources and news partners
TipRanks
·
१६ घण्टा पहिले
Getinge’s Life Science President Eric Honroth to Step Down
www.marketscreener.com
·
१६ घण्टा पहिले
Getinge's Business Area Head Eric Honroth Leaves the Company
TipRanks
·
२१ घण्टा पहिले
Getinge Schedules Q3 2026 Report Release and Investor Call
Profile
Getinge AB is a publicly traded Swedish medical technology company. The company produces and distributes medical products and equipment for the healthcare and life sciences industries. The company is divided into three business areas: Life Science, Acute Care Therapies, and Surgical Workflows. The group employs approximately 12,000 people worldwide. The CEO of the company is Mattias Perjos, and the chairman of the board is Johan Malmquist. With a sales share of around 40%, the United States is by far the most important market for the company due to significantly higher prices and margins there. China and various Western European countries follow. Wikipedia
About Getinge publ AB